Intermittent chemotherapy of pulmonary tuberculosis using rifampicin and isoniazed for primary treatment: the influence of various factors on the frequency off side-effects.
Identifieur interne : 000567 ( PubMed/Corpus ); précédent : 000566; suivant : 000568Intermittent chemotherapy of pulmonary tuberculosis using rifampicin and isoniazed for primary treatment: the influence of various factors on the frequency off side-effects.
Auteurs : M F Aubert ; J C BeaucournuSource :
- Annales de parasitologie humaine et comparee [ 0003-4150 ]
English descriptors
- KwdEn :
- Adolescent, Adult, Animals, Dose-Response Relationship, Drug, Drug Administration Schedule, Ectoparasitic Infestations (veterinary), Female, Foxes, Humans, Isoniazid (adverse effects), Isoniazid (antagonists & inhibitors), Isoniazid (therapeutic use), Male, Middle Aged, Rifampin (administration & dosage), Rifampin (adverse effects), Rifampin (therapeutic use), Siphonaptera, Tuberculosis, Pulmonary (drug therapy).
- MESH :
- chemical , administration & dosage : Rifampin.
- chemical , adverse effects : Isoniazid, Rifampin.
- chemical , antagonists & inhibitors : Isoniazid.
- chemical , therapeutic use : Isoniazid, Rifampin.
- drug therapy : Tuberculosis, Pulmonary.
- veterinary : Ectoparasitic Infestations.
- Adolescent, Adult, Animals, Dose-Response Relationship, Drug, Drug Administration Schedule, Female, Foxes, Humans, Male, Middle Aged, Siphonaptera.
Abstract
After studying more than 1,000 siphonaptera tera collected from about 300 wild carnivora (with a majority of foxes, Vulpes vulpes), in the North-east of France, the authors state more precisely the biology and chorology of the main fleas collected: Pulex irritans, Ctenocephalides felis felis, C, canis, Chaetopsylla globiceps, Ch. rothschildi, Ch. trichosa, Paraceras melis melis. 9 other species are also noted.
PubMed: 937975
Links to Exploration step
pubmed:937975Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Intermittent chemotherapy of pulmonary tuberculosis using rifampicin and isoniazed for primary treatment: the influence of various factors on the frequency off side-effects.</title><author><name sortKey="Aubert, M F" sort="Aubert, M F" uniqKey="Aubert M" first="M F" last="Aubert">M F Aubert</name></author><author><name sortKey="Beaucournu, J C" sort="Beaucournu, J C" uniqKey="Beaucournu J" first="J C" last="Beaucournu">J C Beaucournu</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="????"><PubDate><MedlineDate>1976 Jan-Feb</MedlineDate></PubDate></date><idno type="RBID">pubmed:937975</idno><idno type="pmid">937975</idno><idno type="wicri:Area/PubMed/Corpus">000567</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000567</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Intermittent chemotherapy of pulmonary tuberculosis using rifampicin and isoniazed for primary treatment: the influence of various factors on the frequency off side-effects.</title><author><name sortKey="Aubert, M F" sort="Aubert, M F" uniqKey="Aubert M" first="M F" last="Aubert">M F Aubert</name></author><author><name sortKey="Beaucournu, J C" sort="Beaucournu, J C" uniqKey="Beaucournu J" first="J C" last="Beaucournu">J C Beaucournu</name></author></analytic><series><title level="j">Annales de parasitologie humaine et comparee</title><idno type="ISSN">0003-4150</idno></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Animals</term><term>Dose-Response Relationship, Drug</term><term>Drug Administration Schedule</term><term>Ectoparasitic Infestations (veterinary)</term><term>Female</term><term>Foxes</term><term>Humans</term><term>Isoniazid (adverse effects)</term><term>Isoniazid (antagonists & inhibitors)</term><term>Isoniazid (therapeutic use)</term><term>Male</term><term>Middle Aged</term><term>Rifampin (administration & dosage)</term><term>Rifampin (adverse effects)</term><term>Rifampin (therapeutic use)</term><term>Siphonaptera</term><term>Tuberculosis, Pulmonary (drug therapy)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Rifampin</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Isoniazid</term><term>Rifampin</term></keywords><keywords scheme="MESH" type="chemical" qualifier="antagonists & inhibitors" xml:lang="en"><term>Isoniazid</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Isoniazid</term><term>Rifampin</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Tuberculosis, Pulmonary</term></keywords><keywords scheme="MESH" qualifier="veterinary" xml:lang="en"><term>Ectoparasitic Infestations</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Animals</term><term>Dose-Response Relationship, Drug</term><term>Drug Administration Schedule</term><term>Female</term><term>Foxes</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Siphonaptera</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">After studying more than 1,000 siphonaptera tera collected from about 300 wild carnivora (with a majority of foxes, Vulpes vulpes), in the North-east of France, the authors state more precisely the biology and chorology of the main fleas collected: Pulex irritans, Ctenocephalides felis felis, C, canis, Chaetopsylla globiceps, Ch. rothschildi, Ch. trichosa, Paraceras melis melis. 9 other species are also noted.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">937975</PMID><DateCreated><Year>1976</Year><Month>09</Month><Day>01</Day></DateCreated><DateCompleted><Year>1976</Year><Month>09</Month><Day>01</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0003-4150</ISSN><JournalIssue CitedMedium="Print"><Volume>51</Volume><Issue>1</Issue><PubDate><MedlineDate>1976 Jan-Feb</MedlineDate></PubDate></JournalIssue><Title>Annales de parasitologie humaine et comparee</Title><ISOAbbreviation>Ann Parasitol Hum Comp</ISOAbbreviation></Journal><ArticleTitle>Intermittent chemotherapy of pulmonary tuberculosis using rifampicin and isoniazed for primary treatment: the influence of various factors on the frequency off side-effects.</ArticleTitle><Pagination><MedlinePgn>143-56</MedlinePgn></Pagination><Abstract><AbstractText>After studying more than 1,000 siphonaptera tera collected from about 300 wild carnivora (with a majority of foxes, Vulpes vulpes), in the North-east of France, the authors state more precisely the biology and chorology of the main fleas collected: Pulex irritans, Ctenocephalides felis felis, C, canis, Chaetopsylla globiceps, Ch. rothschildi, Ch. trichosa, Paraceras melis melis. 9 other species are also noted.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Aubert</LastName><ForeName>M F</ForeName><Initials>MF</Initials></Author><Author ValidYN="Y"><LastName>Beaucournu</LastName><ForeName>J C</ForeName><Initials>JC</Initials></Author></AuthorList><Language>fre</Language><PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Contribution à l'étude du parasitisme du Renard (Vulpes vulpes L.) et de quelques autres carnivores sauvages par les Siphonaptères dans le Nord-Est de la France</VernacularTitle></Article><MedlineJournalInfo><Country>France</Country><MedlineTA>Ann Parasitol Hum Comp</MedlineTA><NlmUniqueID>0376525</NlmUniqueID><ISSNLinking>0003-4150</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>V83O1VOZ8L</RegistryNumber><NameOfSubstance UI="D007538">Isoniazid</NameOfSubstance></Chemical><Chemical><RegistryNumber>VJT6J7R4TR</RegistryNumber><NameOfSubstance UI="D012293">Rifampin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004334" MajorTopicYN="Y">Drug Administration Schedule</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004478" MajorTopicYN="N">Ectoparasitic Infestations</DescriptorName><QualifierName UI="Q000662" MajorTopicYN="Y">veterinary</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005589" MajorTopicYN="Y">Foxes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007538" MajorTopicYN="N">Isoniazid</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists & inhibitors</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012293" MajorTopicYN="N">Rifampin</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005423" MajorTopicYN="Y">Siphonaptera</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014397" MajorTopicYN="N">Tuberculosis, Pulmonary</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1976</Year><Month>1</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1976</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1976</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">937975</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Bois/explor/RenardV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000567 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000567 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Bois
|area= RenardV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:937975
|texte= Intermittent chemotherapy of pulmonary tuberculosis using rifampicin and isoniazed for primary treatment: the influence of various factors on the frequency off side-effects.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:937975" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a RenardV1
| This area was generated with Dilib version V0.6.27. |  |